191 related articles for article (PubMed ID: 24694600)
1. Folate-targeted gadolinium-lipid-based nanoparticles as a bimodal contrast agent for tumor fluorescent and magnetic resonance imaging.
Nakamura T; Kawano K; Shiraishi K; Yokoyama M; Maitani Y
Biol Pharm Bull; 2014; 37(4):521-7. PubMed ID: 24694600
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
Oyewumi MO; Yokel RA; Jay M; Coakley T; Mumper RJ
J Control Release; 2004 Mar; 95(3):613-26. PubMed ID: 15023471
[TBL] [Abstract][Full Text] [Related]
4. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
5. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
6. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.
Kamaly N; Kalber T; Thanou M; Bell JD; Miller AD
Bioconjug Chem; 2009 Apr; 20(4):648-55. PubMed ID: 19368341
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-targeted ultrasonic PFOB nanoparticles: Synthesis, characterization and application in tumor-targeted imaging.
Li K; Liu Y; Zhang S; Xu Y; Jiang J; Yin F; Hu Y; Han B; Ge S; Zhang L; Wang Y
Int J Mol Med; 2017 Jun; 39(6):1505-1515. PubMed ID: 28487935
[TBL] [Abstract][Full Text] [Related]
8. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents.
Shiraishi K; Kawano K; Minowa T; Maitani Y; Yokoyama M
J Control Release; 2009 May; 136(1):14-20. PubMed ID: 19331861
[TBL] [Abstract][Full Text] [Related]
11. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.
Swanson SD; Kukowska-Latallo JF; Patri AK; Chen C; Ge S; Cao Z; Kotlyar A; East AT; Baker JR
Int J Nanomedicine; 2008; 3(2):201-10. PubMed ID: 18686779
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
[TBL] [Abstract][Full Text] [Related]
13. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
[TBL] [Abstract][Full Text] [Related]
14. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
16. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.
Cheng Z; Thorek DL; Tsourkas A
Angew Chem Int Ed Engl; 2010; 49(2):346-50. PubMed ID: 19967688
[No Abstract] [Full Text] [Related]
18. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
[TBL] [Abstract][Full Text] [Related]
19. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
20. The effect of ligand density on in vivo tumor targeting of nanographene oxide.
Lee JH; Sahu A; Jang C; Tae G
J Control Release; 2015 Jul; 209():219-28. PubMed ID: 25937319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
